Simon B Lang

Title: Simon B Lang: Innovator in Plasma Kallikrein Inhibitors

Introduction

Simon B Lang is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of plasma kallikrein inhibitors. His work focuses on creating compounds that can effectively treat various disease states.

Latest Patents

Lang holds a patent for plasma kallikrein inhibitors, which provides a compound of Formula (I) and pharmaceutical compositions. These compounds are designed to treat or prevent conditions such as hereditary angioedema, uveitis, and diabetic retinopathy. The invention emphasizes the selective inhibition of plasma kallikrein, showcasing its potential in therapeutic applications.

Career Highlights

Simon B Lang is associated with Merck Sharp & Dohme Corp., where he continues to advance his research and development efforts. His innovative approach has led to the creation of a valuable patent that addresses critical health issues.

Collaborations

Lang has collaborated with notable colleagues, including Salman Jabri and Anthony K Ogawa. These partnerships have contributed to the success of his research and the development of effective pharmaceutical solutions.

Conclusion

Simon B Lang is a distinguished inventor whose work in plasma kallikrein inhibitors has the potential to impact the treatment of various diseases significantly. His contributions to the pharmaceutical industry highlight the importance of innovation in healthcare.